Accumulation of extracellular ADO in the tumor microenvironment favors cancer progression by activating ADO specific G-coupled protein receptors (GPCRs) expressed on immune cells, endothelial cells, fibroblasts and tumor cells. This evidence concerns the gene ADO and neoplasm.